Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The heavy chain diseases: clinical and pathologic features.
Bianchi G, Anderson KC, Harris NL, Sohani AR. Bianchi G, et al. Among authors: anderson kc. Oncology (Williston Park). 2014 Jan;28(1):45-53. Oncology (Williston Park). 2014. PMID: 24683718 Free article. Review.
Targeting the UPS as therapy in multiple myeloma.
Chauhan D, Bianchi G, Anderson KC. Chauhan D, et al. Among authors: anderson kc. BMC Biochem. 2008 Oct 21;9 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-2091-9-S1-S1. BMC Biochem. 2008. PMID: 19007431 Free PMC article. Review.
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease.
Vallet S, Mukherjee S, Vaghela N, Hideshima T, Fulciniti M, Pozzi S, Santo L, Cirstea D, Patel K, Sohani AR, Guimaraes A, Xie W, Chauhan D, Schoonmaker JA, Attar E, Churchill M, Weller E, Munshi N, Seehra JS, Weissleder R, Anderson KC, Scadden DT, Raje N. Vallet S, et al. Among authors: anderson kc. Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5124-9. doi: 10.1073/pnas.0911929107. Epub 2010 Mar 1. Proc Natl Acad Sci U S A. 2010. PMID: 20194748 Free PMC article.
Promising therapies in multiple myeloma.
Bianchi G, Richardson PG, Anderson KC. Bianchi G, et al. Among authors: anderson kc. Blood. 2015 Jul 16;126(3):300-10. doi: 10.1182/blood-2015-03-575365. Epub 2015 Jun 1. Blood. 2015. PMID: 26031917 Free PMC article. No abstract available.
Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.
Guang MHZ, McCann A, Bianchi G, Zhang L, Dowling P, Bazou D, O'Gorman P, Anderson KC. Guang MHZ, et al. Among authors: anderson kc. Leuk Lymphoma. 2018 Mar;59(3):542-561. doi: 10.1080/10428194.2017.1337115. Epub 2017 Jun 13. Leuk Lymphoma. 2018. PMID: 28610537 Free PMC article. Review.
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma.
Xu Y, Fulciniti M, Samur MK, Ho M, Deng S, Liu L, Wen K, Yu T, Chyra Z, Dereibal S, Zhang L, Yao Y, Chakraborty C, Morelli E, Li N, Lopez MA, Perini T, Mu S, An G, Alonso R, Bianchi G, Tai YT, Anderson KC, Qiu L, Munshi NC. Xu Y, et al. Among authors: anderson kc. Blood. 2020 Jul 23;136(4):468-479. doi: 10.1182/blood.2019004147. Blood. 2020. PMID: 32187357 Free PMC article.
1,201 results